Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
[Treatment of relapses of multiple sclerosis (a review)].
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
ISENTRESS® prescribing information
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Exploring the potential of public proteomics data.
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Environmental factors and their regulation of immunity in multiple sclerosis.
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
Treatment of Acute Relapses in Multiple Sclerosis.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
[Neuromyelitis optica in children. Two case reports.]

Pages